Bolden Therapeutics

• Justin R. Fallon

• Anne Valat

  Research scientist

Sources: reporter.nih.gov

• National Institute on Aging

  R41, Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy, R41AG073144, $397K, 2021–2024, Mar 13, 2023

• National Institute on Aging

  R43, Entrepreneurial development award for a novel Alzheimer's disease therapeutic, R43AG078719, $406K, 2022–2024, Sep 1, 2022

Sources: reporter.nih.gov

• Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition

  Founder, Jul 9, 2026

• Characterization of adult hippocampal neurogenesis in adult and aged genetically diverse mice

  Founder, Jun 17, 2025

• A highly feasible, reliable, and fully remote protocol for mobile app-based cognitive assessment in cognitively healthy older adults

  Consulting or advice, Fees or honoraria, Apr 5, 2022

• FOXO3 regulates a common genomic program in aging and glioblastoma stem cells

  Founder, Dec 18, 2021

• Changing and stable chromatin accessibility supports transcriptional overhaul during neural stem cell activation and is altered with age

  Founder, Oct 23, 2021

Sources: pubmed.ncbi.nlm.nih.gov